文献速递乳腺乳腺X线

40岁以下女性基于风险的乳腺X线筛查:来自美国国家乳腺X线数据库的结果

Risk-Based Screening Mammography for Women Aged <40: Outcomes From the National Mammography Database.
PubMed 文献 · J Am Coll Radiol · 2019-09-18

该回顾性研究分析美国国家乳腺X线数据库150家机构2008年1月至2015年12月的5,986,131次筛查乳腺X线数据,比较30–39岁有危险因素女性与40–49岁无危险因素女性的筛查表现。30–39岁具有三种评估危险因素者,在既往已有筛查(发生率筛查)条件下,其癌检出率与召回率与40–49岁平均风险人群相似。作者认为具有这三种特定危险因素之一的女性可能受益于从30岁而非40岁开始筛查。

要点

  • 30–39岁女性中,存在家族史、个人乳腺癌史或致密乳腺任一危险因素者癌检出率显著更高。
  • 30–39岁有上述三种危险因素且既往已有筛查者,癌检出率与召回率与40–49岁平均风险人群相似。
  • 30–34岁与35–39岁两年龄组的癌检出率、召回率及阳性预测值相似。

核心结论

  • 具有家族史、个人乳腺癌史或致密乳腺这三种特定危险因素之一的女性,可能受益于从30岁而非40岁开始筛查。
  • 30–39岁具有三种评估危险因素者在发生率筛查(至少一次既往筛查)条件下,癌检出率与召回率与40–49岁平均风险人群相似。

研究设计与样本

  • 回顾性、符合HIPAA、经机构审查委员会豁免的研究,分析美国国家乳腺X线数据库31个州150家乳腺X线机构的数据。
  • 共纳入2,647,315名女性的5,986,131次筛查乳腺X线,检查时间为2008年1月至2015年12月。
  • 按5岁年龄区间、既往乳腺X线可获得性及特定乳腺癌危险因素(乳腺癌家族史、个人乳腺癌史、致密乳腺)分层。
  • 对每个年龄与危险组计算四项筛查表现指标:召回率(RR)、癌检出率(CDR)、建议活检阳性预测值(PPV2)和实施活检阳性预测值(PPV3)。

诊断标准与关键数值

  • 总体平均癌检出率为每1,000次筛查3.69(95%CI 3.64–3.74)。
  • 总体召回率为9.89%(95%CI 9.87%–9.92%)。
  • 总体建议活检阳性预测值(PPV2)为20.1%(95%CI 19.9%–20.4%)。
  • 总体实施活检阳性预测值(PPV3)为28.2%(95%CI 27.0%–28.5%)。

临床应用与阅片要点

  • 30–34岁与35–39岁女性的癌检出率、召回率及阳性预测值相似。
  • 30–39岁女性中,存在所评估的三种危险因素与显著更高的癌检出率相关。
  • 与目前美国推荐筛查的40–49岁平均风险人群相比,30–39岁具有三种评估危险因素者在发生率筛查(至少一次既往筛查)下癌检出率与召回率相似。
  • 作者认为具有这三种特定危险因素之一的女性可能受益于从30岁而非40岁开始筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: There is insufficient large-scale evidence for screening mammography in women <40 years at elevated risk. This study compares risk-based screening of women aged 30 to 39 with risk factors versus women aged 40 to 49 without risk factors in the National Mammography Database (NMD).

METHODS: This retrospective, HIPAA-compliant, institutional review board-exempt study analyzed data from 150 NMD mammography facilities in 31 states. Patients were stratified by 5-year age intervals, availability of prior mammograms, and specific risk factors for breast cancer: family history of breast cancer, personal history of breast cancer, and dense breasts. Four screening performance metrics were calculated for each age and risk group: recall rate (RR), cancer detection rate (CDR), and positive predictive values for biopsy recommended (PPV2) and biopsy performed (PPV3).

RESULTS: Data from 5,986,131 screening mammograms performed between January 2008 and December 2015 in 2,647,315 women were evaluated. Overall, mean CDR was 3.69 of 1,000 (95% confidence interval: 3.64-3.74), RR was 9.89% (9.87%-9.92%), PPV2 was 20.1% (19.9%-20.4%), and PPV3 was 28.2% (27.0%-28.5%). Women aged 30 to 34 and 35 to 39 had similar CDR, RR, and PPVs, with the presence of the three evaluated risk factors associated with significantly higher CDR. Moreover, compared with a population currently recommended for screening mammography in the United States (aged 40-49 at average risk), incidence screening (at least one prior screening examination) of women aged 30 to 39 with the three evaluated risk factors has similar cancer detection rates and recall rates.

DISCUSSION: Women with one or more of these three specific risk factors likely benefit from screening commencing at age 30 instead of age 40.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Lee CS, Ashih H, Sengupta D, et al. Risk-Based Screening Mammography for Women Aged <40: Outcomes From the National Mammography Database. J Am Coll Radiol. 2019. PMID: 31541655. doi:10.1016/j.jacr.2019.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。